1.7437
전일 마감가:
$1.74
열려 있는:
$1.7001
하루 거래량:
2,768
Relative Volume:
0.02
시가총액:
$64.31M
수익:
$68.72M
순이익/손실:
$-24.01M
주가수익비율:
-2.7695
EPS:
-0.6296
순현금흐름:
$-24.95M
1주 성능:
+2.57%
1개월 성능:
-1.49%
6개월 성능:
-20.38%
1년 성능:
-66.79%
Edap Tms S A Adr Stock (EDAP) Company Profile
EDAP을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
EDAP
Edap Tms S A Adr
|
1.7899 | 64.31M | 68.72M | -24.01M | -24.95M | -0.6296 |
![]()
MCK
Mckesson Corporation
|
725.81 | 88.11B | 359.05B | 3.30B | 5.23B | 25.83 |
![]()
COR
Cencora Inc
|
294.01 | 55.56B | 310.23B | 1.69B | 3.58B | 8.62 |
![]()
CAH
Cardinal Health Inc
|
163.86 | 36.54B | 222.29B | 1.56B | 2.44B | 6.41 |
![]()
HSIC
Henry Schein Inc
|
72.49 | 8.92B | 12.50B | 314.00M | 421.00M | 2.44 |
![]()
OMI
Owens Minor Inc
|
7.635 | 623.64M | 10.42B | -38.77M | 323.54M | -0.51 |
Edap Tms S A Adr Stock (EDAP) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-05-15 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2025-04-04 | 다운그레이드 | Jefferies | Buy → Hold |
2022-11-01 | 개시 | Jefferies | Buy |
2021-04-28 | 개시 | Piper Sandler | Overweight |
2020-04-15 | 개시 | B. Riley FBR | Buy |
2014-07-28 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
2014-06-16 | 개시 | H.C. Wainwright | Buy |
2013-03-05 | 개시 | Northland Capital | Outperform |
2010-11-18 | 재확인 | Morgan Joseph | Buy |
2009-08-20 | 재확인 | Roth Capital | Hold |
2008-11-24 | 재확인 | Roth Capital | Hold |
2008-03-26 | 재확인 | Roth Capital | Hold |
2007-11-09 | 재확인 | Roth Capital | Hold |
2007-03-16 | 재확인 | Roth Capital | Hold |
2007-01-24 | 재확인 | Roth Capital | Hold |
모두보기
Edap Tms S A Adr 주식(EDAP)의 최신 뉴스
EDAP TMS at Jefferies Conference: Strategic Shift to HIFU Therapy - Investing.com
EDAP TMS at Jefferies Conference: Strategic Shift to HIFU Therapy By Investing.com - Investing.com India
edap tms sa announces shareholder meeting for june 2025 By Investing.com - Investing.com India
edap tms sa announces shareholder meeting for june 2025 - Investing.com
H.C. Wainwright cuts EDAP stock price target to $14 By Investing.com - Investing.com South Africa
H.C. Wainwright cuts EDAP stock price target to $14 - Investing.com
EDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual Meeting - GlobeNewswire Inc.
Focal ablation shows promise in prostate cancer trial - Investing.com
Jefferies cuts EDAP TMS stock rating, slashes target to $2 - Investing.com
Piper Sandler cuts EDAP stock price target to $4.50, keeps rating By Investing.com - Investing.com South Africa
Piper Sandler cuts EDAP stock price target to $4.50, keeps rating - Investing.com India
H.C. Wainwright maintains $19 target on EDAP TMS stock - Investing.com India
Earnings call transcript: EDAP TMS Q4 2024 sees revenue growth, stock surges - Investing.com
Allegro Microsystems Inc (ALGM) Beta Value: Understanding the Market Risk - The News Heater
EDAP TMS SA Sponsored ADR to Host Earnings Call - ACCESS Newswire
Investor Network: EDAP TMS SA Sponsored ADR to Host Earnings Call - ACCESS Newswire
EDAP initiates trial for pancreatic cancer treatment - Investing.com India
Earnings call: EDAP TMS sees growth with Focal One HIFU business - Investing.com
EDAP's Avenda Deal For AI-Assisted Cancer Care Likely To Drive Stock - Barchart.com
Biotech & Pharma News, Stocks, FDA Decision, Clinical Trials - RTTNews
Perkins Capital Raises Exposure in EDAP TMS - Insider Monkey
Friday's Top Biotech and Medical Stocks - 24/7 Wall St.
Edap Tms S A Adr (EDAP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):